GroundForce Capital backs Epicutis skincare brand
The company's science-backed formulations, built on proprietary patent-protected actives, are carried in over 4,100 medspas, dermatology practices, and luxury spas nationwide.
Takeaways
- Epicutis is a Professional skincare company developing science-backed products for dermatology and aesthetics practices.
- GroundForce Capital is acquiring Epicutis.
GroundForce Capital has made a growth investment in Epicutis, a science-backed skincare brand that develops clean, minimalist formulations from proprietary biotechnology-derived actives.
Born from over 20 years of bioscience research affiliated with Princeton University through Signum Biosciences, the company has scaled revenue at nearly a 100% compound annual growth rate over the past two years.
The investment will support expansion as the professional channel sees momentum from consumers seeking practitioner-recommended products.
“Epicutis has built something rare in skincare: a genuinely differentiated scientific platform paired with the sales execution to bring it to market at scale,” said Dan Gluck, Co-Founder and Co-Managing Partner of GroundForce Capital.
GroundForce Capital is a founder-led consumer products investor with portfolio brands including Bobbie, Liquid Death, and OWYN.
DC Advisory served as exclusive financial advisor to Epicutis.
Get tomorrow morning's tape in your inbox.
Yesterday's platforms, add-ons, recaps, and exits, cleaned up before the workday starts.